Effect of orlistat on cardiovascular disease risk in obese adults.

@article{Swinburn2005EffectOO,
  title={Effect of orlistat on cardiovascular disease risk in obese adults.},
  author={Boyd A. Swinburn and Dianne Carey and Andrew Peter Hills and Michael Hooper and Seth Marks and J. Proietto and Boyd J G Strauss and Daniel I Sullivan and Tim A Welborn and Ian D Caterson},
  journal={Diabetes, obesity & metabolism},
  year={2005},
  volume={7 3},
  pages={254-62}
}
AIM The aim of this study is to compare the effect of orlistat vs. placebo on the predicted 10-year cardiovascular disease (CVD) risk in obese people with one or more cardiovascular risk factors treated for 12 months, in conjunction with a fat-reduced, but otherwise ad libitum, diet. METHODS A double-blind, randomized, placebo-controlled, parallel study was performed in conjunction with a fat-reduced diet and physical activity advice for 1 year. Participants (n = 339) from eight centres in… CONTINUE READING